109 related articles for article (PubMed ID: 18097585)
1. Ether lipid 1-O-octadecyl-2-O-methyl-3-glycero-phosphocholine inhibits cell-cell adhesion through translocation and clustering of E-cadherin and episialin in membrane microdomains.
Van Slambrouck S; Hilkens J; Steelant WF
Oncol Rep; 2008 Jan; 19(1):123-8. PubMed ID: 18097585
[TBL] [Abstract][Full Text] [Related]
2. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
[TBL] [Abstract][Full Text] [Related]
3. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
4. The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets.
Na HK; Surh YJ
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():204-7. PubMed ID: 18296338
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
6. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
[TBL] [Abstract][Full Text] [Related]
7. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
Petersen ES; Kelley EE; Modest EJ; Burns CP
Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-tumor ether lipids on ordered domains in model membranes.
Heczková B; Slotte JP
FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573
[TBL] [Abstract][Full Text] [Related]
9. Sialylation of E-cadherin does not change the spontaneous or ET-18-OMe-mediated aggregation of MCF-7 human breast cancer cells.
Steelant WF; Recchi MA; Noë VT; Boilly-Marer Y; Bruyneel EA; Verbert A; Mareel MM; Delannoy P
Clin Exp Metastasis; 1999 May; 17(3):245-53. PubMed ID: 10432010
[TBL] [Abstract][Full Text] [Related]
10. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.
Wesseling J; van der Valk SW; Hilkens J
Mol Biol Cell; 1996 Apr; 7(4):565-77. PubMed ID: 8730100
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell division but not nuclear division by 1-O- octadecyl-2-O-methyl-Sn-glycero-3-phosphocholine.
Pushkareva MY; Janoff AS; Mayhew E
Cell Biol Int; 1999; 23(12):817-28. PubMed ID: 10772756
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression.
Wang L; Li Z; Wang C; Yang Y; Sun L; Yao W; Cai X; Wu G; Zhou F; Zha X
Arch Biochem Biophys; 2009 Jan; 481(1):116-22. PubMed ID: 18983973
[TBL] [Abstract][Full Text] [Related]
13. Definition of a direct extracellular interaction between Met and E-cadherin.
Reshetnikova G; Troyanovsky S; Rimm DL
Cell Biol Int; 2007 Apr; 31(4):366-73. PubMed ID: 17336101
[TBL] [Abstract][Full Text] [Related]
14. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
[TBL] [Abstract][Full Text] [Related]
15. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
16. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
17. Alkylphospholipids reversibly open epithelial tight junctions.
Leroy A; de Bruyne GK; Oomen LC; Mareel MM
Anticancer Res; 2003; 23(1A):27-32. PubMed ID: 12680191
[TBL] [Abstract][Full Text] [Related]
18. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.
Hakomori S
Cancer Cells; 1991 Dec; 3(12):461-70. PubMed ID: 1820092
[TBL] [Abstract][Full Text] [Related]
19. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
[TBL] [Abstract][Full Text] [Related]
20. Heterotypic trans-interaction of LI- and E-cadherin and their localization in plasmalemmal microdomains.
Baumgartner W; Wendeler MW; Weth A; Koob R; Drenckhahn D; Gessner R
J Mol Biol; 2008 Apr; 378(1):44-54. PubMed ID: 18342884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
